Elucidation of Epigenetic Inactivation of SMAD8 in Cancer Using Targeted Expressed Gene Display

Cancer Research

Volumn 64, Issue 5, 2004, Pages 1639-1646

  Cheng, Kuang Hung ^a   Ponte, Jose F ^a   Thiagalingam, Sam ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD8 PROTEIN; TUMOR MARKER; DNA BINDING PROTEIN; SMAD8 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; BREAST CANCER; COLON CANCER; CONTROLLED STUDY; EPIGENETICS; GENE; GENE EXPRESSION; GENE INACTIVATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MULTIGENE FAMILY; MUTATION; PRIORITY JOURNAL; SMAD8 GENE; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE SILENCING; GENETICS; NEOPLASM; RNA SPLICING; TUMOR CELL LINE;

CELL LINE, TUMOR; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE SILENCING; HUMANS; NEOPLASMS; RNA SPLICING; SMAD8 PROTEIN; TRANS-ACTIVATORS;

EID: 1642302199     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2688     Document Type: Article

References (42)

1. Thiagalingam, S., Cheng, K-H., Foy, R. L., Lee, H. J., Chinnappan, D., and Ponte, J. F. TGF-β and its Smad connection to cancer. Curr. Genom., 3: 449-476, 2002.
2. Massague, J. TGF-β signal transduction. Annu. Rev. Biochem., 67: 753-791, 1998.
3. Watanabe, T. K., Suzuki, M., Omori, Y., Hishigaki, H., Horie, M., Kanemoto, N., Fujiwara, T., Nakamura, Y., and Takahashi, E. Cloning and characterization of a novel member of the human Mad gene family (MADH6). Genomics, 42: 446-451, 1997.
4. 467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem., 272: 27678-27685, 1997.
5. Nakao, A., Afrakhte, M., Moren, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N. E., Heldin, C. H., and ten Dijke, P. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature (Lond.), 389: 631-635, 1997.
6. Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J., Kawabata, M., and Miyazono, K. Smad6 inhibits signaling by the TGF-β superfamily. Nature (Lond.), 389: 622-626, 1997.
7. Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y. Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Jr., Wrana, J. L., and Falb, D. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell, 89: 1165-1173, 1997.
8. Massague, J., and Wotton, D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J., 19: 1745-1754, 2000.
9. de Caestecker, M. P., Piek, E., and Roberts, A. B. Role of transforming growth factor β signaling in cancer. J. Natl. Cancer Inst. (Bethesda), 92: 1388-1402, 2000.
10. Massague, J., Blain, S. W., and Lo, R. S. TGF-β signaling in growth control, cancer, and heritable disorders. Cell. 103: 295-309, 2000.
11. Letterio, J. J., and Roberts, A. B. Regulation of immune responses by TGF-β. Annu. Rev. Immunol., 16: 137-161, 1998.
12. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogestein, B., and Wilson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Wash. DC), 268: 1336-1338, 1995.
13. Thiagalingam, S., Lengauer, C., Leach, F. S., Schutte, M., Hahn, S. A., Overhauser, J., Willson, J. K. V., Markowitz, S., Hamilton, S. R., Kern, S. E., Kinzler, K. W., and Vogelstein, B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet., 13: 343-346, 1996.
14. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L-C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. MADR2 maps to 18q21 and encodes a TGF-β regulated MAD related protein that is mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
15. Riggins, J. G., Thiagalingam, S., Rozenblum, E., Weinstein, C. L., Kern, S. E., Hamilton, S. R., Willson, J. K. V., Markowitz, S., Kinzler, K. W., and Vogelstein, B. MAD-related genes in the human. Nat. Genet., 13: 347-349, 1996.
16. Schutte, M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Jr., Meltzer, P. S., Hahn, S. A., and Kern, S. E. DPC4 gene in various tumor types. Cancer Res., 56: 2527-2530, 1996.
17. Riggins, J. G., Kinzler, K. W., Vogelstein, B., and Thiagalingam, S. Frequency of Smad gene mutations in human cancers. Cancer Res., 57: 2578-2580, 1997.
18. Korchynskyi, O., Landstrom, M., Stoika, R., Funa, K., Heldin, C. H., ten Dijke, P., and Souchelnytskyi, S. Expression of Smad proteins in human colorectal cancer. Int. J. Cancer. 82: 197-202, 1999.
19. Thiagalingam, S., Cheng, K-H., Lee, H. J., Mineva, N., Thiagalingam, A., and Ponte, J. F. Histone deacetylases: Unique players in shaping the epigenetic histone code. Ann. N. Y. Acad. Sci., 983: 84-100, 2003.
20. Baylin, S. B. Tying it all together: epigenetics, genetics, cell cycle, and cancer. Science (Wash. DC), 277: 1948-1949, 1997.
21. Jones, P. A., and Laird, P. W. Cancer epigenetics comes of age. Nat. Genet., 21: 163-167, 1999.
22. Thiagalingam, S. Molecular detection of Smad4/Smad2 alterations in colorectal tumors: Colorectal Cancer Methods and Protocols. In: S. M. Powell (ed.), Methods in Molecular Medicine, Vol. 50, pp. 149-165. New Jersey: Humana Press, Inc., 2001.
23. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
24. Yagi, K., Goto, D., Hamamoto, T., Takenoshita, S., Kato, M., and Miyazono, K. Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3. J. Biol. Chem., 274: 703-709, 1999.
25. Jiang, Y., Liang, H., Guo, W., Kottickal, L. V., and Nagarajan, L. Differential expression of a novel C-terminally truncated splice form of SMAD5 in hematopoietic stem cells and leukemia. Blood, 95: 3945-3950, 2000.
26. Nishita, M., Ueno, N., and Shibuya, H. Smad8B, a Smad8 splice variant lacking the SSXS site that inhibits Smad8-mediated signalling. Genes Cells, 4: 583-591, 1999.
27. Liang, P. A decade of differential display. Biotechniques, 33, 338-344, 346, 2002.
28. Okada, M., Yamaga, S., Yasuda, S., Weissman, S. M., and Yasukochi, Y. Differential display of protein tyrosine kinase cDNAs from human fetal and adult brains. Biotechniques, 32: 856, 858, 860, 863-865, 2002.
29. Bosch, I., Melichar, H., and Pardee, A. B. Identification of differentially expressed genes from limited amounts of RNA. Nucleic Acids Res., 28: e27, 2000.
30. Ranamukhaarachchi, D. G., Rajeevan, M. S., Vernon, S. D., and Unger, E. R. Modifying differential display polymerase chain reaction to detect relative changes in gene expression profiles. Anal. Biochem., 306: 343-346, 2002.
31. Zujewski, J. A. "Build quality in"-HER2 testing in the real world. J. Natl. Cancer Inst. (Bethesda), 94: 788-789, 2002.
32. Hogan, B. L. M. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev., 10: 1580-1594, 1996.
33. Hogan, B. L. M. Morphogenesis. Cell, 96: 225-233, 1999.
34. Massague, J., and Chen, Y. G. Controlling TGF-β signaling. Genes Dev., 14: 627-644, 2000.
35. Attisano, L., and Wrana, J. L. Smads as transcriptional co-modulators. Curr. Opin. Cell Biol., 12: 235-243, 2000.
36. Miyazono, K., Kusanagi, K., and Inoue, H. Divergence and convergence of TGF-β/ BMP signaling. J. Cell. Physiol., 187: 265-276, 2001.
37. Coleman, R. E., Smith, P., and Rubens, R. D. Clinical course and prognostic factors following bone recurrence from breast cancer. Br. J. Cancer, 77: 336-340, 1998.
38. Coleman, R. E., and Rubens, R. D. The clinical course of bone metastases from breast cancer. Br. J. Cancer, 55: 61-66, 1987.
39. Reddi, A. H., Roodman, D., Freeman, C., and Mohla, S. Mechanisms of tumor metastasis to the bone: challenges and opportunities. J. Bone Miner. Res., 18: 190-194, 2003.
40. Reddi, A. H. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat. Biotechnol., 16: 247-252, 1998.
41. Howe, J. R., Howe, J. R., Bair, J. L., Sayed, M. G., Anderson, M. E., Mitros, F. A., Petersen, G. M., Velculescu, V. E., Traverso, G., and Vogelstein, B. Germline mutations of the gene encoding bone morphogenetic protein 1A in juvenile polyposis. Nat. Genet., 28: 184-187, 2001.
42. Sayed, M. G., Ahmed, A. F., Ringold, J. R., Anderson, M. E., Bair, J. L., Mitros, F. A., Lynch, H. T., Tinley, S. T., Petersen, G. M., Giardiello, F. M., Vogelstein, B., and Howe, J. R. Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann. Surg. Oncol., 9: 901-906, 2002.